F1000Research (Apr 2017)

Recent advances in the management and understanding of macular degeneration [version 1; referees: 2 approved]

  • Sepehr Bahadorani,
  • Michael Singer

DOI
https://doi.org/10.12688/f1000research.10998.1
Journal volume & issue
Vol. 6

Abstract

Read online

Current management of age-related macular degeneration (AMD) is directed at intravitreal injection of vascular endothelial growth factor (VEGF) inhibitors for the treatment of wet AMD and supplementation with oral antioxidants for the treatment of dry AMD. In this article, we will review recent clinical trials for the treatment of dry and wet AMD.

Keywords